S&P 500   3,841.99 (+0.01%)
DOW   30,879.78 (-0.38%)
QQQ   326.06 (+0.20%)
AAPL   141.58 (+1.80%)
MSFT   226.35 (+0.18%)
FB   275.38 (+0.32%)
GOOGL   1,871.30 (-1.12%)
AMZN   3,286.45 (-0.18%)
TSLA   865.38 (+2.21%)
NVDA   537.87 (-1.94%)
BABA   259.72 (+0.43%)
CGC   32.49 (-3.88%)
GE   10.91 (-1.80%)
MU   80.07 (-2.69%)
AMD   93.20 (+0.44%)
NIO   59.54 (-3.89%)
T   28.83 (-0.35%)
F   11.05 (-4.08%)
ACB   10.13 (-4.88%)
BA   201.11 (-2.30%)
DIS   170.72 (-1.19%)
NFLX   555.25 (-1.76%)
GILD   66.96 (+0.03%)
S&P 500   3,841.99 (+0.01%)
DOW   30,879.78 (-0.38%)
QQQ   326.06 (+0.20%)
AAPL   141.58 (+1.80%)
MSFT   226.35 (+0.18%)
FB   275.38 (+0.32%)
GOOGL   1,871.30 (-1.12%)
AMZN   3,286.45 (-0.18%)
TSLA   865.38 (+2.21%)
NVDA   537.87 (-1.94%)
BABA   259.72 (+0.43%)
CGC   32.49 (-3.88%)
GE   10.91 (-1.80%)
MU   80.07 (-2.69%)
AMD   93.20 (+0.44%)
NIO   59.54 (-3.89%)
T   28.83 (-0.35%)
F   11.05 (-4.08%)
ACB   10.13 (-4.88%)
BA   201.11 (-2.30%)
DIS   170.72 (-1.19%)
NFLX   555.25 (-1.76%)
GILD   66.96 (+0.03%)
S&P 500   3,841.99 (+0.01%)
DOW   30,879.78 (-0.38%)
QQQ   326.06 (+0.20%)
AAPL   141.58 (+1.80%)
MSFT   226.35 (+0.18%)
FB   275.38 (+0.32%)
GOOGL   1,871.30 (-1.12%)
AMZN   3,286.45 (-0.18%)
TSLA   865.38 (+2.21%)
NVDA   537.87 (-1.94%)
BABA   259.72 (+0.43%)
CGC   32.49 (-3.88%)
GE   10.91 (-1.80%)
MU   80.07 (-2.69%)
AMD   93.20 (+0.44%)
NIO   59.54 (-3.89%)
T   28.83 (-0.35%)
F   11.05 (-4.08%)
ACB   10.13 (-4.88%)
BA   201.11 (-2.30%)
DIS   170.72 (-1.19%)
NFLX   555.25 (-1.76%)
GILD   66.96 (+0.03%)
S&P 500   3,841.99 (+0.01%)
DOW   30,879.78 (-0.38%)
QQQ   326.06 (+0.20%)
AAPL   141.58 (+1.80%)
MSFT   226.35 (+0.18%)
FB   275.38 (+0.32%)
GOOGL   1,871.30 (-1.12%)
AMZN   3,286.45 (-0.18%)
TSLA   865.38 (+2.21%)
NVDA   537.87 (-1.94%)
BABA   259.72 (+0.43%)
CGC   32.49 (-3.88%)
GE   10.91 (-1.80%)
MU   80.07 (-2.69%)
AMD   93.20 (+0.44%)
NIO   59.54 (-3.89%)
T   28.83 (-0.35%)
F   11.05 (-4.08%)
ACB   10.13 (-4.88%)
BA   201.11 (-2.30%)
DIS   170.72 (-1.19%)
NFLX   555.25 (-1.76%)
GILD   66.96 (+0.03%)
Log in
NYSE:ENZ

Enzo Biochem SEC Filings & 10K Form

$2.99
-0.07 (-2.29 %)
(As of 01/25/2021 12:38 PM ET)
Add
Compare
Today's Range
$2.99
Now: $2.99
$3.16
50-Day Range
$2.30
MA: $2.58
$3.20
52-Week Range
$1.56
Now: $2.99
$4.85
Volume6,285 shs
Average Volume366,749 shs
Market Capitalization$143.21 million
P/E RatioN/A
Dividend YieldN/A
Beta0.89

SEC Filings

Enzo Biochem (NYSE:ENZ) SEC Filings

DateFilerForm TypeView
01/15/2021
3:39 PM
Enzo Biochem (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/15/2021
2:42 PM
Enzo Biochem (Subject)
Evermore Global Advisors, LLC (Filed by)
Form SC 13G/A
01/15/2021
7:30 AM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
01/13/2021
8:45 PM
Enzo Biochem (Issuer)
TAGLIAFERRI MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
8:44 PM
Enzo Biochem (Issuer)
WEINER BARRY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
8:43 PM
Enzo Biochem (Issuer)
Fischer Rebecca J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
8:40 PM
Enzo Biochem (Issuer)
RABBANI ELAZAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
8:40 PM
Enzo Biochem (Issuer)
Perlysky Dov (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
8:37 PM
Bench David (Reporting)
Enzo Biochem (Issuer)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
8:37 PM
Enzo Biochem (Issuer)
Enzo Biochem (Issuer)
Walters Ian B. (Reporting)
Walters Ian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:36 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
3:00 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
2:04 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
01/05/2021
2:02 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/31/2020
4:01 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/31/2020
4:01 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
12/30/2020
2:51 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form SC 13D/A
12/30/2020
5:09 AM
Enzo Biochem (Filer)
Form DEFA14A
12/29/2020
8:25 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
12/29/2020
8:24 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/29/2020
7:13 AM
Enzo Biochem (Filer)
Form DEFA14A
12/28/2020
8:20 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/28/2020
8:18 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
12/28/2020
7:30 AM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
12/28/2020
7:01 AM
Enzo Biochem (Filer)
Form DEFA14A
12/23/2020
4:26 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
12/23/2020
4:25 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/23/2020
3:54 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DEFC14A
12/23/2020
5:04 AM
Enzo Biochem (Filer)
Form DEFA14A
12/22/2020
7:47 AM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/21/2020
3:21 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form PRRN14A
12/21/2020
10:30 AM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/18/2020
3:36 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/17/2020
11:43 AM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
4:09 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form SC 13D/A
12/15/2020
11:30 AM
Enzo Biochem (Filer)
Form DEFR14A
12/14/2020
3:55 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2020
7:15 AM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/11/2020
4:15 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form PREC14A
12/11/2020
3:49 PM
Enzo Biochem (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/09/2020
1:00 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form DFAN14A
12/08/2020
4:05 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/07/2020
4:18 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/04/2020
7:30 AM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D/A
12/03/2020
4:00 PM
Enzo Biochem (Issuer)
Walters Ian B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/27/2020
4:00 PM
Enzo Biochem (Subject)
Roumell Asset Management, LLC (Filed by)
Form SC 13D
11/27/2020
2:30 PM
Enzo Biochem (Filer)
Form DEF 14A
11/25/2020
4:00 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/23/2020
4:10 PM
Enzo Biochem (Issuer)
TAGLIAFERRI MARY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/18/2020
2:31 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form SC 13D/A
11/16/2020
4:03 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
3:54 PM
Enzo Biochem (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/12/2020
3:15 PM
Enzo Biochem (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2020
3:31 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
3:46 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
7:19 PM
BLANK FABIAN (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2020
7:06 PM
CLEMENS PETER J IV (Reporting)
Enzo Biochem (Issuer)
Form 4/A
04/28/2020
8:40 PM
CLEMENS PETER J IV (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
8:35 PM
Enzo Biochem (Issuer)
Fischer Rebecca J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
8:31 PM
Enzo Biochem (Issuer)
Perlysky Dov (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2020
3:45 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
3:47 PM
Enzo Biochem (Filer)
Form 8-K/A
04/09/2020
3:30 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
4:02 PM
Enzo Biochem (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2020
3:05 PM
Enzo Biochem (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/05/2020
4:21 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
3:50 PM
Enzo Biochem (Issuer)
WEINER BARRY W (Reporting)
Form 4/A
02/27/2020
11:47 AM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form SC 13D/A
02/26/2020
4:18 PM
Bench David (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
2:15 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
02/19/2020
4:29 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
02/19/2020
1:45 PM
CLEMENS PETER J IV (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
8:20 AM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
4:21 PM
Enzo Biochem (Filer)
Form DEFA14A
02/18/2020
4:10 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
5:06 AM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form SC 13D/A
02/14/2020
5:04 AM
CLEMENS PETER J IV (Reporting)
Enzo Biochem (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2020
8:37 AM
Enzo Biochem (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/11/2020
4:32 PM
Enzo Biochem (Filer)
Form PRER14A
02/11/2020
8:13 AM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
4:03 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
4:00 PM
Enzo Biochem (Filer)
Form DEFA14A
02/06/2020
4:17 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
02/06/2020
4:11 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
02/05/2020
10:45 AM
BlackRock Inc. (Filed by)
Enzo Biochem (Subject)
Form SC 13G/A
01/31/2020
6:07 AM
Enzo Biochem (Filer)
Form PRER14A
01/30/2020
9:08 AM
Enzo Biochem (Subject)
Evermore Global Advisors, LLC (Filed by)
Form SC 13G/A
01/29/2020
3:44 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
01/29/2020
8:57 AM
Enzo Biochem (Subject)
WELLINGTON TRUST Co N A (Filed by)
Form SC 13G/A
01/29/2020
7:55 AM
Enzo Biochem (Filer)
Form DEFA14A
01/29/2020
7:43 AM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
10:27 AM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
01/21/2020
3:36 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
01/17/2020
4:29 PM
Enzo Biochem (Filer)
Form DEFA14A
01/17/2020
4:29 PM
Enzo Biochem (Filer)
Form 8-K/A
01/17/2020
4:21 PM
Enzo Biochem (Filer)
Form DEFA14A
01/17/2020
3:29 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
01/16/2020
4:18 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
01/16/2020
4:15 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
01/14/2020
4:15 PM
Enzo Biochem (Subject)
Harbert Discovery Fund, LP (Filed by)
Form DFAN14A
This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.